Genetically altered mice

Citations 251-260 of 267 total displayed.

Past content (since Feb 1999):

Atherosclerosis and Lipoproteins
Dietary ß-Carotene and ${alpha}$ -Tocopherol Combination Does Not Inhibit Atherogenesis in an ApoE–Deficient Mouse Model: Aviv Shaish, Jacob George, Boris Gilburd, Pnina Keren, Hana Levkovitz, and Dror Harats
Arterioscler Thromb Vasc Biol 1999;19:1470-1475 [Abstract] [Full text]

Atherosclerosis and Lipoproteins
Estrogen-Mediated Increases in LDL Cholesterol and Foam Cell–Containing Lesions in Human ApoB100xCETP Transgenic Mice: Steven H. Zuckerman, Glenn F. Evans, Judi A. Schelm, Patrick I. Eacho, and George Sandusky
Arterioscler Thromb Vasc Biol 1999;19:1476-1483 [Abstract] [Full text]

Atherosclerosis and Lipoproteins
Monocyte Chemoattractant Protein-1 Accelerates Atherosclerosis in Apolipoprotein E-Deficient Mice: Robert J. Aiello, Patricia-Ann K. Bourassa, Saralyn Lindsey, Weifan Weng, Edward Natoli, Barrett J. Rollins, and Patrice M. Milos
Arterioscler Thromb Vasc Biol 1999;19:1518-1525 [Abstract] [Full text]

Atherosclerosis and Lipoproteins Western-Type Diets Induce Insulin Resistance and Hyperinsulinemia in LDL Receptor-Deficient Mice But Do Not Increase Aortic Atherosclerosis Compared With Normoinsulinemic Mice in Which Similar Plasma Cholesterol Levels Are Achieved by a Fructose-Rich Diet: Shiva Merat, Florencia Casanada, Mary Sutphin, Wulf Palinski, and Peter D. Reaven
Arterioscler Thromb Vasc Biol 1999;19:1223-1230 [Abstract] [Full text]

Atherosclerosis and Lipoproteins Modification of Type III VLDL, Their Remnants, and VLDL From ApoE-Knockout Mice by p-Hydroxyphenylacetaldehyde, a Product of Myeloperoxidase Activity, Causes Marked Cholesteryl Ester Accumulation in Macrophages: Stewart C. Whitman, Stanley L. Hazen, David B. Miller, Robert A. Hegele, Jay W. Heinecke, and Murray W. Huff
Arterioscler Thromb Vasc Biol 1999;19:1238-1249 [Abstract] [Full text]

Atherosclerosis and Lipoproteins
Increased Cholesterol Efflux Potential of Sera From ApoA-I_Milano Carriers and Transgenic Mice: Guido Franceschini, Laura Calabresi, Giulia Chiesa, Cinzia Parolini, Cesare R. Sirtori, Monica Canavesi, and Franco Bernini
Arterioscler Thromb Vasc Biol 1999;19:1257-1262 [Abstract] [Full text]

Atherosclerosis and Lipoproteins
Role of Group II Secretory Phospholipase A₂ in Atherosclerosis : 1. Increased Atherogenesis and Altered Lipoproteins in Transgenic Mice Expressing Group IIa Phospholipase A₂: Boris Ivandic, Lawrence W. Castellani, Xu-Ping Wang, Jian-Hua Qiao, Margarete Mehrabian, Mohamad Navab, Alan M. Fogelman, David S. Grass, Mark E. Swanson, Maria C. de Beer, Frederick de Beer, and Aldons J. Lusis
Arterioscler Thromb Vasc Biol 1999;19:1284-1290 [Abstract] [Full text]

Atherosclerosis and Lipoproteins
Role of Group II Secretory Phospholipase A₂ in Atherosclerosis : 2. Potential Involvement of Biologically Active Oxidized Phospholipids: Norbert Leitinger, Andrew D. Watson, Susan Y. Hama, Boris Ivandic, Jian-Hua Qiao, Joakim Huber, Kym F. Faull, David S. Grass, Mohamad Navab, Alan M. Fogelman, Frederick C. de Beer, Aldons J. Lusis, and Judith A. Berliner
Arterioscler Thromb Vasc Biol 1999;19:1291-1298 [Abstract] [Full text]

Original Contributions
Ultrastructure of Early Lipid Accumulation in ApoE-Deficient Mice: M. Tamminen, G. Mottino, J. H. Qiao, J. L. Breslow, and J. S. Frank
Arterioscler Thromb Vasc Biol 1999;19:847-853 [Abstract] [Full text]

Original Contributions
Increased Atherosclerosis in ApoE and LDL Receptor Gene Knock-Out Mice as a Result of Human Cholesteryl Ester Transfer Protein Transgene Expression: Andrew S. Plump, Lori Masucci-Magoulas, Can Bruce, Charles L. Bisgaier, Jan L. Breslow, and Alan R. Tall
Arterioscler Thromb Vasc Biol 1999;19:1105-1110 [Abstract] [Full text]

Subspecialty Collections Home

Show Genetically altered mice
collections from other journals.